Macrophage phenotype modulation by CXCL4 in atherosclerosis

Frontiers in Physiology

Volumn 3 JAN, Issue , 2012, Pages

  Gleissner, Christian A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; CXCL4; Differentiation; M4; Macrophage; Polarization

Indexed keywords

EID: 84866175383     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00001     Document Type: Article

References (50)

1. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., Staels, B., and Chinetti-Gbaguidi, G. (2007). PPARgamma activationprimes human monocytes into alternative m2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143.
2. Boyle, J. J., Harrington, H. A., Piper, E., Elderfield, K., Stark, J., Landis, R. C., and Haskard, D. O. (2009). Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 174, 1097-1108.
3. Boyle, J. J., Johns, M., Lo, J., Chiodini, A., Ambrose, N., Evans, P. C., Mason, J. C., and Haskard, D. O. (2011). Heme induces heme oxygenase 1 via nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 31, 2685-2691.
4. Brandt, E., Petersen, F., Ludwig, A., Ehlert, J. E., Bock, L., and Flad, H. D. (2000). The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J. Leukoc. Biol. 67, 471-478.
5. Buechler, C., Ritter, M., Orso, E., Langmann, T., Klucken, J., and Schmitz, G. (2000). Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiin-flammatory stimuli. J. Leukoc. Biol. 67, 97-103.
6. Cho, H. J., Shashkin, P., Gleissner, C. A., Dunson, D., Jain, N., Lee, J. K., Miller, Y., and Ley, K. (2007). Induction of dendritic cell-like pheno-type in macrophages during foam cell formation. Physiol. Genomics 29, 149-160.
7. de Villiers, W. J., Smith, J. D., Miyata, M., Dansky, H. M., Darley, E., and Gordon, S. (1998). Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein e. Arterioscler. Thromb. Vasc. Biol. 18, 631-640.
8. Galkina, E. V., and Ley, K. (2009). Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 27, 165-197.
9. Gear, A. R., and Camerini, D. (2003). Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10, 335-350.
10. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., and Ley, K. (2010). Development of mono-cytes, macrophages, and dendritic cells. Science 327, 656-661.
11. Gleissner, C. A. (2012). Platelet-derived chemokines in atherogenesis: what's new? Curr. Vasc. Pharmacol. (in press).
12. Gleissner, C. A., Shaked, I., Erbel, C., Bockler, D., Katus, H. A., and Ley, K. (2010a). CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ. Res. 106, 203-211.
13. Gleissner, C. A., Shaked, I., Little, K. M., and Ley, K. (2010b). CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J. Immunol. 184, 4810-4818.
14. Gleissner, C. A., von Hundelshausen, P., and Ley, K. (2008). Platelet chemokines in vascular disease. Arterioscler. Thromb. Vasc. Biol. 28, 1920-1927.
15. Gordon, S., and Taylor, P. R. (2005). Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
16. Greve, H., Cully, Z., Blumberg, P., and Kresse, H. (1988). Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J. Biol. Chem. 263, 12886-12892.
17. Hanamura, T., Motoyoshi, K., Yoshida, K., Saito, M., Miura, Y., Kawashima, T., Nishida, M., and Takaku, F. (1988). Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 72, 886-892.
18. Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., and Ley, K. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein e. Nat. Med. 9, 61-67.
19. Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., Habenicht, A. J., Ziegler-Heitbrock, L., and Randolph, G. J. (2010). Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115, e10-e19.
20. Juan, S.-H., Lee, T.-S., Tseng, K.-W., Liou, J.-Y., Shyue, S.-K., Wu, K. K., and Chau, L.-Y. (2001). Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein e-deficient mice. Circulation 104, 1519-1525.
21. Kasper, B., Brandt, E., Brandau, S., and Petersen, F. (2007). Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J. Immunol. 179, 2584-2591.
22. Kasper, B., and Petersen, F. (2011). Molecular pathways of platelet factor 4/CXCL4 signaling. Eur. J. Cell Biol. 90, 521-526.
23. Koenen, R. R., von Hundelshausen, P., Nesmelova,I.V., Zernecke,A., Liehn, E. A., Sarabi, A., Kramp, B. K., Pic-cinini, A. M., Paludan, S. R., Kowal-ska, M. A., Kungl, A. J., Hackeng, T. M., Mayo, K. H., and Weber, C. (2009). Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipi-demic mice. Nat. Med. 15, 97-103.
24. Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S., Silverstein, R., Hoff, H. F., and Freeman, M. W. (2002). Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipopro-tein leading to lipid loading in macrophages. J. Biol. Chem. 277, 49982-49988.
25. Lasagni, L., Francalanci, M., Annun-ziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Marra, F., Romagnani, S., Serio, M., and Romagnani, P. (2003). An alternatively spliced variant of CXCR3 mediates the inhibition of endothe-lial cell growth induced by ip-10, mig, and I-tac, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537-1549.
26. Mantovani, A., Garlanda, C., and Locati, M. (2009). Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 29, 1419-1423.
27. Martinez, F. O., Gordon, S., Locati, M., and Mantovani, A. (2006). Tran-scriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311.
28. Martinez, F. O., Sica, A., Manto-vani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13, 453-461.
29. Moore, K. J., and Tabas, I. (2011). Macrophages in the pathogene-sis of atherosclerosis. Cell 145, 341-355.
30. Mueller, A., Meiser, A., McDonagh, E. M., Fox,J. M.,Petit,S. J., Xanthou, G., Williams, T. J., and Pease, J. E. (2008). CXCL4-induced migration of activated t lymphocytes is mediated by the chemokine receptor CXCR3. J. Leukoc. Biol. 83, 875-882.
31. Nassar, T., Sachais, B. S., Akkawi, S., Kowalska, M. A., Bdeir, K., Leiters-dorf, E., Hiss, E., Ziporen, L., Avi-ram, M., Cines, D., Poncz, M., and Higazi, A. A. (2003). Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J. Biol. Chem. 278, 6187-6193.
32. Newby, A. C. (2008). Metallopro-teinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 28, 2108-2114.
33. Orozco, L. D., Kapturczak, M. H., Bara-jas, B., Wang, X., Weinstein, M. M., Wong, J., Deshane, J., Bolisetty, S., Shaposhnik, Z., Shih, D. M., Agar-wal, A., Lusis, A. J., and Araujo, J. A. (2007). Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 100, 1703-1711.
34. Pitsilos, S., Hunt, J., Mohler, E. R., Prab-hakar, A. M., Poncz, M., Dawicki, J., Khalapyan, T. Z., Wolfe, M. L., Fairman, R., Mitchell, M., Carpenter, J., Golden, M. A., Cines, D. B., and Sachais, B. S. (2003). Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb. Haemost. 90, 1112-1120.
35. Porcheray, F., Viaud, S., Rimaniol, A. C., Leone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., and Gras, G. (2005). Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489.
36. Sachais, B. S., Kuo, A., Nassar, T., Morgan, J., Kariko, K., Williams, K. J., Feldman, M., Aviram, M., Shah, N., Jarett, L., Poncz, M., Cines, D. B., and Higazi, A. A. (2002). Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipopro-tein on the cell surface. Blood 99, 3613-3622.
37. Sachais, B. S., Turrentine, T., Dawicki McKenna, J. M., Rux, A. H., Rader, D., and Kowalska, M. A. (2007). Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in c57bl/6 and apoe-/- mice. Thromb. Haemost. 98, 1108-1113.
38. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
39. Schaer, C. A., Schoedon, G., Imhof, A., Kurrer, M. O., and Schaer, D. J. (2006). Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective tran-scriptional response of macrophages to hemoglobin. Circ. Res. 99, 943-950.
40. Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D., and Petersen, F. (2000). The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95, 1158-1166.
41. Stanley, E. R., Chen, D. M., and Lin, H. S. (1978). Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 274, 168-170.
42. Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Inter-leukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
43. Stoger, J. L., Goossens, P., and de Winther, M. P. (2010). Macrophage heterogeneity: relevance and functional implications in atherosclerosis. Curr. Vasc. Pharmacol. 8, 233-248.
44. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550.
45. Tushinski, R. J., Oliver, I. T., Guilbert, L. J., Tynan, P. W., Warner, J. R., and Stanley, E. R. (1982). Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28, 71-81.
46. von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E., Hackeng, T. M., and Weber, C. (2005). Het-erophilic interactions of platelet factor 4 and RANTES promote mono-cyte arrest on endothelium. Blood 105, 924-930.
47. Waldo, S. W., Li, Y., Buono, C., Zhao, B., Billings, E. M., Chang, J., and Kruth, H. S. (2008). Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172, 1112-1126.
48. Wolfs, I. M., Donners, M. M., and de Winther, M. P. (2011). Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb. Haemost. 106, 763-771.
49. Yet, S. F., Layne, M. D., Liu, X., Chen, Y. H., Ith, B., Sibinga, N. E., and Perrella, M. A. (2003). Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17, 1759-1761.
50. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., and Shultz, L. D. (1990). The murine mutation osteopetro-sis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442-444.